Imatinib Recruiting Phase 3 Trials for Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02611492A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults